FindTrial
Sign In

Assessment of steroid use in COPD patients.

Prescription pattern of steroid in patients presenting Acute Exacerbation of Chronic Obstructive Pulmonary Disorder (AECOPD) -A prospective observational study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2023/02/049850
Enrollment
152
Registered
2023-02-20
Start date
Unknown
Completion date
Unknown
Last updated
2023-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J441- Chronic obstructive pulmonary disease with (acute) exacerbation

Interventions

None listed

Sponsors

Kasturba Hospital Manipal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inpatients admitted for AECOPD.

Exclusion criteria

Exclusion criteria: Discharged against medical advice (DAMA), Other lung disease, COVID19, respiratory failure

Design outcomes

Primary

MeasureTime frame
incidence of infection, ICU admission, need for mechanical ventilation.Timepoint: at one point in time (0 months)—

Secondary

MeasureTime frame
duration of therapy, length of hospital stay, 30 days mortality.Timepoint: 0 months—

Countries

India

Contacts

Public ContactAditi Dhawan

Manipal College Of Pharmaceutical Sciences, Manipal

salim.kt@manipal.edu9656798071

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026